Platelet growth factors: potential impact on transfusion medicine

被引：17

作者：

Kuter, DJ

Cebon, J

Harker, LA

Petz, LD

McCullough, J

机构：

[1] Massachusetts Gen Hosp, Dept Clin Hematol, Boston, MA 02114 USA

[2] Austin & Repatriat Med Ctr, Lundwig Inst, Oncol Unit, Heidelberg, Vic, Australia

[3] Emory Univ, Div Hematol Oncol, Atlanta, GA 30322 USA

[4] Univ Calif Los Angeles, Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA

[5] Univ Minnesota, Dept Lab Med, Minneapolis, MN 55455 USA

来源：

TRANSFUSION | 1999年 / 39卷 / 03期

关键词：

D O I：

10.1046/j.1537-2995.1999.39399219292.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：321 / 332

页数：12

共 61 条

[1] BLEEDING DUE TO THROMBOCYTOPENIA IN ACUTE LEUKEMIAS AND REEVALUATION OF THE PROPHYLACTIC PLATELET TRANSFUSION POLICY [J].

ADERKA, D ;

PRAFF, G ;

SANTO, M ;

WEINBERGER, A ;

PINKHAS, J .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1986, 291 (03) :147-151

[2]

Aldaabil R, 1997, BLOOD, V90, P4517

[3] Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-mpl [J].

Alexander, WS ;

Roberts, AW ;

Nicola, NA ;

Li, RL ;

Metcalf, D .

BLOOD, 1996, 87 (06) :2162-2170

[4]

Archimbaud E., 1996, Blood, V88, p447A

[5] IDENTIFICATION AND CLONING OF A MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR THAT IS A LIGAND FOR THE CYTOKINE RECEPTOR MPL [J].

BARTLEY, TD ;

BOGENBERGER, J ;

HUNT, P ;

LI, YS ;

LU, HS ;

MARTIN, F ;

CHANG, MS ;

SAMAL, B ;

NICHOL, JL ;

SWIFT, S ;

JOHNSON, MJ ;

HSU, RY ;

PARKER, VP ;

SUGGS, S ;

SKRINE, JD ;

MEREWETHER, LA ;

CLOGSTON, C ;

HSU, E ;

HOKOM, MM ;

HORNKOHL, A ;

CHOI, E ;

PANGELINAN, M ;

SUN, Y ;

MAR, V ;

MCNINCH, J ;

SIMONET, L ;

JACOBSEN, F ;

XIE, C ;

SHUTTER, J ;

CHUTE, H ;

BASU, R ;

SELANDER, L ;

TROLLINGER, D ;

SIEU, L ;

PADILLA, D ;

TRAIL, G ;

ELLIOTT, G ;

IZUMI, R ;

COVEY, T ;

CROUSE, J ;

GARCIA, A ;

XU, W ;

DELCASTILLO, J ;

BIRON, J ;

COLE, S ;

HU, MCT ;

PACIFICI, R ;

PONTING, I ;

SARIS, C ;

WEN, D .

CELL, 1994, 77 (07) :1117-1124

[6]

Basser, 1997, BLOOD, V90, P2513

[7] Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer [J].

Basser, RL ;

Rasko, JEJ ;

Clarke, K ;

Cebon, J ;

Green, MD ;

Hussein, S ;

Alt, C ;

Menchaca, D ;

Tomita, D ;

Marty, J ;

Fox, RM ;

Begley, CG .

LANCET, 1996, 348 (9037) :1279-1281

[8]

Basser RL, 1997, BLOOD, V89, P3118

[9] INCIDENCE OF HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH CANCER [J].

BELT, RJ ;

LEITE, C ;

HAAS, CD ;

STEPHENS, RL .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 239 (24) :2571-2574

[10]

BERNSTEIN MJ, 1987, JAMA-J AM MED ASSOC, V257, P1777

← 1 2 3 4 5 6 7 →